id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2010-0023-0005,DEA,DEA-2010-0023,Scheduling Review Document_Dronabinol,Supporting & Related Material,Final Economic Impact Analysis,2010-11-03T04:00:00Z,2010,11,,,2011-03-23T18:40:13Z,,0,0,0900006480b7f84e
DEA-2010-0023-0004,DEA,DEA-2010-0023,HHS recommendation 2,Supporting & Related Material,Final Regulatory Flexibility Act Analysis,2010-11-02T04:00:00Z,2010,11,,,2011-03-23T18:40:13Z,,0,0,0900006480b7d934
DEA-2010-0023-0002,DEA,DEA-2010-0023,HHS Recommendation,Supporting & Related Material,Initial Regulatory Flexibility Act Analysis,2010-11-01T04:00:00Z,2010,11,,,2011-03-23T18:40:13Z,,0,0,0900006480b7d0b3
DEA-2010-0023-0001,DEA,DEA-2010-0023,Listing of Approved Drug Products Containing Dronabinol in Schedule III,Proposed Rule,NPRM,2010-11-01T04:00:00Z,2010,11,2010-11-01T04:00:00Z,2011-01-04T04:59:59Z,2014-01-18T19:41:52Z,2010-27502,0,0,0900006480b7c824
DEA-2010-0023-0003,DEA,DEA-2010-0023,Dronabinol scheduling review document,Supporting & Related Material,,2010-11-01T00:00:00Z,2010,11,,,2011-03-23T18:40:13Z,,0,1,0900006480b7d0b4